More on that story in a moment. But we begin tonight with a decline in the biotech sector. The decline in that sector, its worst of the year, was fueled not by a failed drug trial but by president ial hopeful Hillary Clinton. The nasdaq biotech index fell about 4 1 2 after clinton said in a tweet that as president shed crack down on what she sees as price gouging in the pharmaceutical industry. She promised more details tomorrow. Now, those comments were in response to a report in the New York Times of a 5,000 price increase, virtually overnight, in a 62yearold specialty drug. Now, weve talked a lot about the high cost of breakthrough new drugs coming to market. But as meg tirrell reports, older drugs arent immune. Reporter for a Small Company its making big waves for the drug industry. Turing pharmaceuticals, a private Company Founded by a former hedge fund manager, is the target of outrage over the price of its drug deraprin. The medicine cost 13. 50 a tablet before turing acquired t
More on that story in a moment. But we begin tonight with a decline in the biotech sector. The decline in that sector, its worst of the year, was fueled not by a failed drug trial but by president ial hopeful Hillary Clinton. The nasdaq biotech index fell about 4 1 2 after clinton said in a tweet that as president shed crack down on what she sees as price gouging in the pharmaceutical industry. She promised more details tomorrow. Now, those comments were in response to a report in the New York Times of a 5,000 price increase, virtually overnight, in a 62yearold specialty drug. Now, weve talked a lot about the high cost of breakthrough new drugs coming to market. But as meg tirrell reports, older drugs arent immune. Reporter for a Small Company its making big waves for the drug industry. Turing pharmaceuticals, a private Company Founded by a former hedge fund manager, is the target of outrage over the price of its drug deraprin. The medicine cost 13. 50 a tablet before turing acquired t
More on that story in a moment. But we begin tonight with a decline in the biotech sector. The decline in that sector, its worst of the year, was fueled not by a failed drug trial but by president ial hopeful Hillary Clinton. The nasdaq biotech index fell about 4 1 2 after clinton said in a tweet that as president shed crack down on what she sees as price gouging in the pharmaceutical industry. She promised more details tomorrow. Now, those comments were in response to a report in the New York Times of a 5,000 price increase, virtually overnight, in a 62yearold specialty drug. Now, weve talked a lot about the high cost of breakthrough new drugs coming to market. But as meg tirrell reports, older drugs arent immune. Reporter for a Small Company its making big waves for the drug industry. Turing pharmaceuticals, a private Company Founded by a former hedge fund manager, is the target of outrage over the price of its drug deraprin. The medicine cost 13. 50 a tablet before turing acquired t
Nothing like a subtle winner duking it out against a loser. Stocks dont fight each other. But on days like today with the dow sank 130 points, s p tumbled and then the nasdaq, wow, 1. 38 , the clash is so obvious we cant resit resist visiting the battlefield. So who is getting the spoils and whos getting vaporized . While almost all stocks ended down today, you have to think about relative winners and losers and that means you want to continue to bet on the major cord, to bet on value, not growth, as growth just got pulverized. Well value held its own and outperformed the benchmarks that a what Money Managers want. This contest its nothing new. These two cohorts have been going at it all year, but its only recently that the match has become one sided. As the Fastest Growing companies with little or no profit have been crushed. Sell sell sell. Sell sell sell. On both up and down days often. While the most Profitable Enterprises with decent growth, sure, they take lumps on days when the
LED Driving Power Supply Market To Witness Huge Growth By 2033 briefingwire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from briefingwire.com Daily Mail and Mail on Sunday newspapers.